INCB-99280 drug page Clinical trials

Trials with INCB-99280

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

1Trials
0Recruiting
3Countries
8Planned patients

Showing 1–1 of 1

Interventional Study of INCB 99280 With Ipilimumab in Participants With Select Solid Tumors
Finished Phase 1 8 patients NCT05909995

The purpose of this study is to characterize the safety, tolerability, PK, and efficacy of INCB 99280 in combination with ipilimumab in participants with select solid tumors.

United States, Canada, South Africa Aug 2023 – Nov 2024 Interventional
Combined with: Ipilimumab